N Nwokolo
Overview
Explore the profile of N Nwokolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katlama C, Bisshop F, Bogner J, Perez Elias M, Di Giambenedetto S, Clarke E, et al.
HIV Med
. 2024 May;
25(7):873-884.
PMID: 38760011
Objectives: Women represent >50% of people with HIV globally but have historically been underrepresented in clinical trials. We evaluated the efficacy and safety of switching to dolutegravir/lamivudine (DTG/3TC) vs continuing...
2.
Gedela K, Luis H, Loverian R, Maharani S, Rajus N, Wignall F, et al.
Digit Health
. 2022 May;
8:20552076221090049.
PMID: 35548711
Introduction: HIV prevalence among men who have sex with men has increased in Indonesia, amid reports of growing stigma against lesbian, gay, bisexual and transgender individuals and policies that have...
3.
Dragovic B, Rymer J, Nwokolo N
J Virus Erad
. 2022 Mar;
8(1):100064.
PMID: 35242357
Advances in HIV care over the last 30 years have transformed a virtually fatal condition into a chronic, manageable one. Antiretroviral therapy (ART) has dramatically changed the outlook for people...
4.
Rapid initiation of antiretroviral therapy in those with newly diagnosed HIV infection in London, UK
Whitlock G, Carbonell M, Blackwell S, Nwokolo N
HIV Med
. 2019 Aug;
20(10):699-703.
PMID: 31424598
Objectives: In July 2016, as a result of patient demand, we introduced a rapid initiation option (RIO) to offer a first medical appointment and antiretroviral therapy (ART) initiation within 2 ...
5.
Whitlock G, Boccino S, Kanagalinghan U, Nwokolo N
Sex Transm Infect
. 2017 Jul;
93(5):325.
PMID: 28729517
No abstract available.
6.
Wang X, Nwokolo N, Korologou-Linden R, Hill A, Whitlock G, Day-Weber I, et al.
HIV Med
. 2017 Jun;
19(1):1-6.
PMID: 28657199
Objectives: The National Health Service in England (NHS England) does not provide pre-exposure prophylaxis (PrEP) against HIV, forcing people to purchase generic versions on the internet. However, there are concerns...
7.
Whitlock G, Nwokolo N, McOwan A
HIV Med
. 2015 Aug;
16(8):519-20.
PMID: 26245890
We describe the characteristics of HIV post-exposure prophylaxis (PEP) recipients and PEP indications at 56 Dean Street, a central London sexual health clinic. PEP was prescribed on 577 occasions. Most...
8.
OKeeffe C, Nwokolo N, McOwan A, Whitlock G
Int J STD AIDS
. 2014 Aug;
26(8):590-2.
PMID: 25122580
UK post-exposure prophylaxis (PEP) guidelines were updated by the British Association for Sexual Health and HIV (BASHH) in 2011. In 2013, we changed policy to omit day 5 PEP follow-up...
9.
Wingrove I, McOwan A, Nwokolo N, Whitlock G
Sex Transm Infect
. 2014 Aug;
90(6):474.
PMID: 25118322
No abstract available.
10.
Hughes A, Hope R, Nwokolo N, Ward B, Jones R, Von Schweitzer M, et al.
HIV Med
. 2012 Sep;
14(3):145-52.
PMID: 22998645
Objectives: The aim of the study was to examine the service use and characteristics of young people diagnosed with HIV infection aged under 25 years in order to design appropriate...